SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Strategy, Inc. engages in the development of fixed-income instruments that provide investors varying degrees of economic exposure to bitcoin. It executes bitcoin acquisition, capital management, and capital markets strategies. The company was founded by Michael J. Saylor and Sanjeev K. Bansal on November 17, 1989, and is headquartered in Tysons Corner, VA.

Strategy Inc. - Ordinary Shares - Class A

Strategy

MicroStrategy is experiencing heightened volatility and intense community polarization as investors weigh the impact of its leveraged Bitcoin strategy against mounting concerns over shareholder dilution and dividend sustainability. The stock is a focal point for intense debate, with critics highlighting potential insolvency risks and liquidation pressures, while bullish participants view the current price compression as a generational buying opportunity tied to the long-term trajectory of Bitcoin.

Lucid Group, Inc. manufactures electric vehicles. It designs, develops, and builds energy storage systems for electric vehicles and supplies automakers with the battery pack system needed to power hybrid, plug-in, and electric vehicles. The company was founded in December 2007 and is headquartered in Newark, CA.

Lucid Group Inc

Lucid Group is trending as investors react to the company's recent workforce reductions and leadership changes, while social media sentiment remains deeply polarized between bulls betting on the upcoming robotaxi partnership with Uber and bears expressing frustration over the stock's long-term decline and potential dilution. Community discussion is heavily focused on the high short interest and speculative theories regarding institutional control, even as supporters defend the firm's technological achievements and future product roadmap.

Bloom Energy Corp. engages in the manufacture and installation of a solid oxide fuel-cell based power generation platform. Its product, Bloom Energy Server, converts standard low-pressure natural gas or biogas into electricity through an electrochemical process without combustion. The company was founded by K. R. Sridhar, John Finn, Jim McElroy, Matthias Gottmann, and Dien Nguyen on January 18, 2001, and is headquartered in San Jose, CA.

Bloom Energy Corp - Ordinary Shares - Class A

Bloom Energy is currently drawing intense investor attention as its technology is increasingly viewed as a critical infrastructure solution to the AI power bottleneck, despite recent volatility driven by institutional rotation and project updates. The community remains deeply divided, with many bulls pointing to a robust hyperscaler backlog and long-term grid integration potential, while skeptics emphasize valuation concerns and the risks associated with scaling operations.

Critical Metals Corp. engages in the mining, exploration, and development of lithium metals. It owns Wolfsberg Project and Tanbreez Project. The company was founded on October 24, 2022 and is headquartered in British Virgin Islands.

Critical Metals Corp.

Critical Metals Corp. is trending as investors monitor Japan's recent move to explore rare earth opportunities in Greenland, sparking optimism that Tanbreez's heavy rare earth reserves will become a pivotal strategic asset for Western supply chain independence. Community sentiment remains polarized, with many longs citing the project's long-term geopolitical importance and recent drilling program as potential catalysts for a rerating, while others express frustration over the timing of management communications and the stock's recent price volatility.

Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which is engaged in the discovery and development of therapeutics for the treatment of rare diseases. The company was founded on July 22, 1980, and is headquartered in Cambridge, MA.

Sarepta Therapeutics Inc

Sarepta Therapeutics is experiencing intense trading volume and volatility as investors actively debate the company's valuation, potential takeover rumors, and the upcoming annual meeting. Community sentiment is sharply divided between those calling for leadership changes due to prolonged price pressure and others highlighting the company's established commercial portfolio and late-stage pipeline as catalysts for a long-term recovery.

QUALCOMM, Inc. engages in developing and commercializing foundational technologies and products used in mobile devices and other wireless products. It operates through the following segments: Qualcomm CDMA Technologies (QCT), Qualcomm Technology Licensing (QTL), and Qualcomm Strategic Initiatives (QSI). The QCT segment develops and supplies integrated circuits and system software based on technologies for use in voice and data communications, networking, application processing, multimedia, and global positioning system products. The QTL segment grants licenses and provides rights to use portions of the firm's intellectual property portfolio. The QSI segment focuses on opening new or expanding opportunities for its technologies and supporting the design and introduction of new products and services for voice and data communications. The company was founded by Franklin P. Antonio, Adelia A. Coffman, Andrew Cohen, Klein Gilhousen, Irwin Mark Jacobs, Andrew J. Viterbi, and Harvey P. White in July 1985 and is headquartered in San Diego, CA.

Qualcomm, Inc.

Qualcomm is drawing significant attention as investors position for its upcoming Investor Day, where the company is expected to showcase its strategic pivot toward data center infrastructure and AI-native architecture. The stock has been a flashpoint for debate, with the community actively navigating volatility fueled by large-scale options activity and speculation surrounding potential hyperscaler partnerships and long-term revenue targets.

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

ImmunityBio is trending as retail investors speculate on potential inclusion in the Russell 1000 index, driving significant options activity and ongoing conflict between bullish sentiment and short sellers. The community remains focused on the potential for a short squeeze and upcoming clinical catalysts as they debate the stock's long-term valuation.

ON Semiconductor Corp. engages in the provision of intelligent power and sensing solutions with a primary focus on automotive and industrial markets. It operates through the following segments: Power Solutions Group (PSG), Analog and Mixed-Signal Group (AMG), and Intelligent Sensing Group (ISG). The PSG segment offers discrete, module, and integrated semiconductor products that perform multiple application functions, including power switching, signal conditioning, and circuit protection. The AMG segment designs and develops analog, mixed-signal, power management integrated circuits, sensor interface devices, power conversion, signal chain, and voltage regulation devices. The ISG focuses on the design and development of complementary metal oxide semiconductor image sensors, image signal processors, single photon detectors, including silicon photomultipliers, single photon avalanche diode arrays, and short-wavelength infrared products, as well as actuator drivers for autofocus and image stabilization. The company was founded on July 4, 1999 and is headquartered in Scottsdale, AZ.

ON Semiconductor Corp.

ON Semiconductor is drawing significant investor interest as the market closely monitors the tension between its surging AI data center revenue and ongoing weakness in the automotive and industrial sectors. Community sentiment is deeply polarized, with active debates centered on whether the current stock performance represents a sustainable breakout driven by infrastructure demand or an overextended valuation vulnerable to structural dilution and sector-wide headwinds.

The Wendy’s Co. engages in operating, developing, and franchising a system of quick-service restaurants. It operates through the following segments: Wendy’s U.S., Wendy’s International, and Global Real Estate and Development. The Wendy’s U.S. segment includes the operation and franchising of Wendy’s restaurants in the U.S. The Wendy’s International segment is involved in the operation and franchising of Wendy’s restaurants in countries and territories other than the U.S. The Global Real Estate and Development segment focuses on real estate activity for owned sites and sites leased from third parties. The company was founded by R. David Thomas on November 15, 1969 and is headquartered in Dublin, OH.

Wendy`s Co - Ordinary Shares - Class A

Wendy's Co

Wendys is trending as retail investors rally behind the stock, viewing its solid fundamentals and dividend payments as a superior alternative to previous meme stock plays. The community is actively discussing a potential short squeeze, focusing on high short interest and the strategic accumulation of shares to push the price past key resistance levels.

AbCellera Biologics, Inc. engages in the development of therapeutic antibodies. It offers antibody discovery platform that searches, decodes and analyzes natural immune systems to find antibodies that can be developed to prevent and treat disease. The company was founded by Carl Lars G. Hensen, Kathleen Lisaingo, Kevin Heyries, Véronique Lecault and Daniel Da Costa on November 8, 2012 and is headquartered in Vancouver, Canada.

AbCellera Biologics Inc

AbCellera Biologics is experiencing a period of intense volatility and market scrutiny as investors weigh its long-term AI-driven platform potential against the results of its Phase 1 clinical data. The community remains deeply divided, with some highlighting strong institutional accumulation and the upcoming Phase 2 catalyst for its lead molecule, while others express frustration over multi-year share price underperformance and the company's reliance on pipeline developments rather than immediate revenue growth.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$SMMR @Maraaj 

Looks promising, but late on their fins.  Copped a yield sign.  Likely pick some up when/if they file.

Maraaj

StockTwits For Android 

Symmetry Technologies Ord Shs

 

Looks promising, but late on their fins.  Copped a yield sign.  Likely pick some up when/if they file.

Arbuckle McShitteé

@Squirrely_McShitty 
Ya fins were for previous company .. uc inc. No relation to current ceo, company.
Not happy about that.
I do know they are working or submitted finra paperwork and per ceo on twitter otc to follow after that.
Personally would like to see OTCMarkets updated. But im not 100% on all that stuff.

 
Ya fins were for previous company .. uc inc. No relation to current ceo, company.
Not happy about that.
I do know they are working or submitted finra paperwork and per ceo on twitter otc to follow after that.
Personally would like to see OTCMarkets updated. But im not 100% on all that stuff.

@Squirrely_McShitty 
No threat of going expert, because they are alternate reporting. They have a huge grace period to getting things done.

 
No threat of going expert, because they are alternate reporting. They have a huge grace period to getting things done.